Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection

Neurology

Volumn 72, Issue 17, 2009, Pages 1465-1472

  Lentz, M R ^a   Kim, W K ^b   Lee, V ^a   Bazner, S ^a   Halpern, E F ^a   Venna, N ^a   Williams, K ^c   Rosenberg, E S ^a   Gonzalez R G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c BOSTON COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; GLUTAMINE; N ACETYLASPARTIC ACID; ASPARTIC ACID; BIOLOGICAL MARKER; DRUG DERIVATIVE; N-ACETYLASPARTATE;

ADULT; ARTICLE; BRAIN DISEASE; BRAIN LEVEL; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; T LYMPHOCYTE; WESTERN BLOTTING; ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAIN; CD4 CD8 RATIO; DISEASE COURSE; EARLY DIAGNOSIS; FRONTAL LOBE; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; METHODOLOGY; MIDDLE AGED; NERVE CELL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY;

ADULT; AIDS DEMENTIA COMPLEX; ASPARTIC ACID; BIOLOGICAL MARKERS; BRAIN; CD4-CD8 RATIO; DISEASE PROGRESSION; EARLY DIAGNOSIS; FRONTAL LOBE; GLUTAMIC ACID; HIV SEROPOSITIVITY; HUMANS; IMMUNOPHENOTYPING; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; NEURONS; T-LYMPHOCYTES;

EID: 67549130940     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181a2e90a     Document Type: Article

References (40)

1. Kassutto S, Rosenberg ES. Primary HIV type 1 infection. Clin Infect Dis 2004;38:1447-1453.
2. Fischer-Smith T, Croul S, Adeniyi A, et al. Macrophage/ microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy. Am J Pathol 2004;164:2089-2099.
3. Rosenberg ES, Altfeld M, Poon SH, et al. Immune control of HIV-1 after early treatment of acute infection. Nature 2000;407:523-526.
4. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68:4650-4655.
5. Alter G, Teigen N, Ahern R, et al. Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J Infect Dis 2007;195:1452-1460.
6. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-579.
7. Chang L, Ernst T, Leonido-Yee M, Walot I, Singer E. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology 1999;52:100-108.
8. Yiannoutsos CT, Ernst T, Chang L, et al. Regional patterns of brain metabolites in AIDS dementia complex. Neuroimage 2004;23:928-935.
9. Greco JB, Westmoreland SV, Ratai EM, et al. In vivo 1H MRS of brain injury and repair during acute SIV infection in the macaque model of neuroAIDS. Magn Reson Med 2004;51:1108-1114.
10. Lentz MR, Kim JP, Westmoreland SV, et al. Quantitative neuropathologic correlates of changes in ratio of N-acetylaspartate to creatine in macaque brain. Radiology 2005;235:461-468.
11. Fuller RA, Westmoreland SV, Ratai E, et al. A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS. BMC Neurosci 2004; 5:10.
12. Willams K, Westmoreland S, Greco J, et al. Magnetic resonance spectroscopy reveals that activated monocytes contribute to the neuronal injury in SIV neuroAIDS. J Clin Invest 2005;115:2534-2545.
13. Marcondes MC, Burudi EM, Huitron-Resendiz S, et al. Highly activated CD8(-) T cells in the brain correlate with early central nervous system dysfunction in simian immunodeficiency virus infection. J Immunol 2001;167: 5429-5438.
14. von Geldern G, Cepok S, Nolting T, et al. CD8 T-cell subsets and viral load in the cerebrospinal fluid of therapynaive HIV-infected individuals. AIDS 2007;21:250-253.
15. Kassutto S, Johnston MN, Rosenberg ES. Incomplete HIV type 1 antibody evolution and seroreversion in acutely infected individuals treated with early antiretroviral therapy. Clin Infect Dis 2005;40:868-873.
16. Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd RE. Automated single-voxel proton MRS: technical development and multisite verification. Magn Reson Med 1994;31:365-373.
17. Keller MA, Venkatraman TN, Thomas A, et al. Altered neurometabolite development in HIV-infected children: correlation with neuropsychological tests. Neurology 2004;62:1810-1817.
18. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679.
19. Hicks CB, Gay C, Ferrari G. Acute HIV infection: the impact of anti-retroviral treatment on cellular immune responses. Clin Exp Immunol 2007;149:211-216.
20. Mogensen TH, Marinovskij E, Larsen CS. Acute demyelinating encephalomyelitis (ADEM) as initial presentation of primary HIV infection. Scand J Infect Dis 2007;39: 630-634.
21. Yoshizawa T, Motonishi S, Saitoh M. [Case of acute primary HIV infection with meningoencephalitis demonstrating high signal intensity of the bilateral globus pallidus in T2-weighted MRI.] Rinsho Shinkeigaku 2007;47:597- 600.
22. McArthur JC, Becker PS, Parisi JE, et al. Neuropathological changes in early HIV-1 dementia. Ann Neurol 1989; 26:681-684.
23. Mahadevan A, Shankar SK, Satishchandra P, et al. Characterization of human immunodeficiency virus (HIV)- infected cells in infiltrates associated with CNS opportunistic infections in patients with HIV clade C infection. J Neuropathol Exp Neurol 2007;66:799-808.
24. Williams KC, Corey S, Westmoreland SV, et al. Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 2001;193:905-915.
25. Gray F, Scaravillio F, Everall I, et al. Neuropathology of early HIV-1 infection. Brain Pathol 1996;6:1-15.
26. Clements JE, Babas T, Mankowski JL, et al. The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J Infect Dis 2002; 186:905-913.
27. Broderick DF, Wippold FJ, Clifford DB, Kido D, Wilson BS. White matter lesions and cerebral atrophy on MR images in patients with and without AIDS dementia complex. AJR Am J Roentgenol 1993;161:177-181.
28. Heindel WC, Jernigan TL, Archibald SL, Achim CL, Masliah E, Wiley CA. The relationship of quantitative brain magnetic resonance imaging measures to neuropathologic indexes of human immunodeficiency virus infection. Arch Neurol 1994;51:1129-1135.
29. Lee PL, Yiannoutsos CT, Ernst T, et al. A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis. J Magn Reson Imaging 2003;17: 625-633.
30. Chang L, Ernst T, Leonido-Yee M, et al. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 1999;53:782-789.
31. Stankoff B, Tourbah A, Suarez S, et al. Clinical and spectroscopic improvement in HIV-associated cognitive impairment. Neurology 2001;56:112-115.
32. Lopez-Villegas D, Lenkinski RE, Frank I. Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. PNAS 1997;94:9854-9859.
33. Thompson PM, Dutton RA, Hayashi KM, et al. Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4- T lymphocyte decline. PNAS 2005;102: 15647-15652.
34. Mohamad MA, Sacktor NC, Skolasky RL, Moxley RT, Pomper MG, Barker PB. 3 Tesla MR spectroscopy reveals decreased glutamate and glutamine levels in frontal white matter in HIV-associated dementia. ISMRM 2007;15:2140.
35. Sailasuta N, Shriner K, Ross B. Evidence of reduced glutamate in the frontal lobe of HIV seropositive patients. NMR Biomed 2008;22:326-331.
36. Hess C, Altfeld M, Thomas SY, et al. HIV-1 specific CD8- T cells with an effector phenotype and control of viral replication. Lancet 2004;363:863-866.
37. von Herrath M, Oldstone MB, Fox HS. Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques. J Immunol 1995;154:5582-5589.
38. Kaul M, Lipton SA. Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. J Neuroimmune Pharmacol 2006;1:138-151.
39. Streeck H, Brumme ZL, Anastario M, et al. Antigen load and viral sequence diversification determine the functional profile of HIV-1 specific CD8- T cells. PLoS Med 2008;5:e100.
40. Neuenburg JK, Cho TA, Nilsson A, et al. T-cell activation and memory phenotypes in cerebrospinal fluid during HIV infection. JAIDS 2005;39:16-22.